back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-04-24 13:50 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-275,250
-11,010 vol $25.00 each |
0 | |
| Filed 2019-04-24 13:48 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-102,683 vol |
0 | |
| Filed 2019-04-24 13:47 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,597,375
-63,895 vol $25.00 each |
0 | |
| Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,010 | |
| Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+850 vol |
3,165 | |
| Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
102,683 | |
| Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+896 vol |
2,315 | |
| Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+759 vol |
1,419 | |
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
660 | |
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
||
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
||
| Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
660 | |
| Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
63,895 | ||
| Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 |